1. P-228Tumor Treating Fields (150 kHz) combined with FOLFOX inhibits gastric cancer in vitro. (2nd July 2019) Authors: Zeevi, E; Gotlib, K; Shnaiderman, R; Munster, M; Porat, Y; Voloshin, T; Davidi, S; Shteingauz, A; Kaynan, N; Giladi, M; Kirson, E; Weinberg, U; Kinzel, A; Palti, Y Journal: Annals of oncology Issue: Volume 30(2019)Supplement 4 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. P-250The combined treatment of 150 kHz Tumor Treating Fields (TTFields) and sorafenib shows In vitro and in vivo efficacy in hepatocellular carcinoma. (2nd July 2019) Authors: Davidi, S; Gotlib, K; Zeevi, E; Shnaiderman, R; Voloshin, T; Giladi, M; Kinzel, A; Weinberg, U; Kirson, E; Palti, Y Journal: Annals of oncology Issue: Volume 30(2019)Supplement 4 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. P02.04 Tumor treating fields induce immunogenic cell death resulting in enhanced antitumor efficacy when combined with anti-PD-1 therapy. (19th September 2018) Authors: Voloshin, T; David, S; Porat, Y; Shteingauz, A; Munster, M; Kaynan, N; Giladi, M; Kirson, E; Weinberg, U; Palti, Y Journal: Neuro-oncology Issue: Volume 20(2018)Supplement 3 Page Start: iii272 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. P02.04 Tumor treating fields induce immunogenic cell death resulting in enhanced antitumor efficacy when combined with anti-PD-1 therapy. (19th September 2018) Authors: Voloshin, T; David, S; Porat, Y; Shteingauz, A; Munster, M; Kaynan, N; Giladi, M; Kirson, E; Weinberg, U; Palti, Y Journal: Neuro-oncology Issue: Volume 20(2018)Supplement 3 Page Start: iii272 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. P04.15 Autophagy induction following TTFields application serves as a survival mechanism mediated by AMPK signaling. (19th September 2018) Authors: Porat, Y; Shteingauz, A; Voloshin, T; Schneiderman, R; Giladi, M; Kirson, E; Weinberg, U; Kinzel, A; Palti, Y Journal: Neuro-oncology Issue: Volume 20(2018)Supplement 3 Page Start: iii281 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. P04.16 Tumor treating fields affect invasion properties and cell morphology of various cancer cells. (19th September 2018) Authors: Schneiderman, R; Giladi, M; Zeevi, E; Shteingauz, A; Voloshin, T; Porat, Y; Munster, M; Kirson, E; Palti, Y Journal: Neuro-oncology Issue: Volume 20(2018)Supplement 3 Page Start: iii282 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. P04.17 Cancer cell lines response to tumor treating fields: results of a meta-analysis. (19th September 2018) Authors: Lavy Shahaf, G; Giladi, M; Schneiderman, R; Kinzel, A; Weinberg, U; Kirson, E; Palti, Y Journal: Neuro-oncology Issue: Volume 20(2018)Supplement 3 Page Start: iii282 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. P04.17 Cancer cell lines response to tumor treating fields: results of a meta-analysis. (19th September 2018) Authors: Lavy Shahaf, G; Giladi, M; Schneiderman, R; Kinzel, A; Weinberg, U; Kirson, E; Palti, Y Journal: Neuro-oncology Issue: Volume 20(2018)Supplement 3 Page Start: iii282 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. P04.55 Efficacy of Tumor Treating Fields (TTFields) and aurora B kinase inhibitor. (19th September 2018) Authors: Krex, D; Bartmann, P; Temme, A; Schneiderman, R; Voloshin, T; Giladi, M; Kinzel, A; Kirson, E; Weinberg, U; Palti, Y Journal: Neuro-oncology Issue: Volume 20(2018)Supplement 3 Page Start: iii292 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. P04.59 Modeling the safety of topical agents for skin toxicity associated with tumor treating fields therapy in glioblastoma. (19th September 2018) Authors: Lacouture, M; Hershkovich, H; Giladi, M; Blat, R; Bomzon, Z; Kirson, E; Weinberg, U; Palti, Y Journal: Neuro-oncology Issue: Volume 20(2018)Supplement 3 Page Start: iii293 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗